FDA Inspection 1123650 — Agada Biosciences Corp
The FDA completed an inspection of Agada Biosciences Corp on Mar 12, 2020 in Halifax. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 12, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Halifax (Canada)
Additional Details
Bioanalytical BA/BE